Close Menu

Goodbye, Dolly?

SciAm has an article and excerpts of an interview with Ian Wilmut, the first person to use somatic cell nuclear transfer to clone a mammal. Wilmut has almost entirely switched his research focus to creating iPS cells because, like many others, he sees that weeding through the ethical and technical issues around SCNT just isn't worth it.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.